Zobrazeno 1 - 10
of 352
pro vyhledávání: '"Vibeke, Andersen"'
Autor:
Nathalie Fogh Rasmussen, Caroline Moos, Laura Helene Keiding Gregersen, Zainab Hikmat, Vibeke Andersen, Anders Green, Tine Jess, Gunvor Iben Madsen, Andreas Kristian Pedersen, Sofie Ronja Petersen, Lene Juel Kjeldsen
Publikováno v:
Systematic Reviews, Vol 13, Iss 1, Pp 1-33 (2024)
Abstract Background Inflammatory bowel diseases (IBDs) are associated with high healthcare utilization. This systematic review aimed to summarize what is known about the impact of sex, income, and education on the likelihood of bowel surgery, hospita
Externí odkaz:
https://doaj.org/article/ba70a51cb57d4adfa3506a9a340a890a
Autor:
Jonas Halfvarson, Robin Christensen, Vibeke Andersen, Jens Kjeldsen, Johan D Söderholm, Anja Fejrskov, Johannes David Füchtbauer, Lóa G Davíðsdóttir, Martin Rejler, Dirk Repsilber, Marte Høivik
Publikováno v:
BMJ Open, Vol 14, Iss 7 (2024)
Introduction The absence of reliable prognostic markers poses a challenge to the management of inflammatory bowel disease (IBD). Patients with aggressive disease may not receive sufficient treatment with conventional ‘step-up’ therapy, whereas a
Externí odkaz:
https://doaj.org/article/3920b6fc9c4d410f9890b8643ed775ab
Autor:
Jonas Halfvarson, Robin Christensen, Vibeke Andersen, Jens Kjeldsen, Marte Lie Hoivik, Claus Aalykke, Johan D Söderholm, Anja Fejrskov, Johannes David Füchtbauer, Lóa G Davíðsdóttir, Michael Dam Jensen, Joachim Høg Mortensen, Lene Nyholm Nielsen, Martin Rejler, Dirk Repsilber
Publikováno v:
BMJ Open, Vol 14, Iss 5 (2024)
Introduction Inflammatory bowel disease (IBD), including ulcerative colitis and Crohn’s disease, can be challenging to diagnose, and treatment outcomes are difficult to predict. In the NORDTREAT cohort study, a Nordic prospective multicentre study,
Externí odkaz:
https://doaj.org/article/1f2f1480c9e74af989e1ef25d51dcec0
Autor:
Rownaq Fares Al-Sofi, Mie Siewertsen Bergmann, Claus Henrik Nielsen, Vibeke Andersen, Lone Skov, Nikolai Loft
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 11, p 5793 (2024)
Genetic biomarkers could potentially lower the risk of treatment failure in chronic inflammatory diseases (CID) like psoriasis, psoriatic arthritis (PsA), rheumatoid arthritis (RA), and inflammatory bowel disease (IBD). We performed a systematic revi
Externí odkaz:
https://doaj.org/article/0ecc7c541e7848938b1b5be5bc8bbf9a
Autor:
Marcio Luis Acencio, Marek Ostaszewski, Alexander Mazein, Philip Rosenstiel, Konrad Aden, Neha Mishra, Vibeke Andersen, Prodromos Sidiropoulos, Aggelos Banos, Anastasia Filia, Souad Rahmouni, Axel Finckh, Wei Gu, Reinhard Schneider, Venkata Satagopam
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Chronic inflammatory diseases (CIDs), including inflammatory bowel disease (IBD), rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) are thought to emerge from an impaired complex network of inter- and intracellular biochemical interact
Externí odkaz:
https://doaj.org/article/8589f1d5f6624ef8a4bff349664b2a94
Autor:
Kala M. Mehta, Karin Lottrup Petersen, Steve Goodman, Henrik Toft Sørensen, Martin Bøgsted, Jeppe Dørup Olesen, Sylvia Burks, Richard E. Shaw, Jens Dahlgaard Hove, Jakob Ousager, Carlos Milla, Vibeke Andersen, Niels Ejskjær, Vibeke Brix-Christensen, Shomit Ghose, Andreas Kjær, Peter V. Chin-Hong
Publikováno v:
BMC Medical Education, Vol 23, Iss 1, Pp 1-7 (2023)
Abstract Background Most medical educational programs emphasize clinical observation or clinical skill acquisition, fewer focus upon research. The Danish-American Research Exchange (DARE) program, sponsored by the Lundbeck Foundation, is unique in th
Externí odkaz:
https://doaj.org/article/8156e9d24f92435e8cd45ba0627fd63b
Autor:
Allan Stensballe, Tue Bjerg Bennike, Gitte Ravn-Haren, Alicja Mortensen, Christopher Aboo, Lina Almind Knudsen, Malte C. Rühlemann, Svend Birkelund, Corinne Bang, Andre Franke, Ulla Vogel, Axel Kornerup Hansen, Vibeke Andersen
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
Inflammatory Bowel Disease (IBD) affects approximately 0.3% of the global population, with incidence rates rising dramatically worldwide. Emerging evidence points to an interplay between exposome factors such as diet and gut microbiota, host genetics
Externí odkaz:
https://doaj.org/article/b43747722c244cafb9e89394487df904
Autor:
Neha Mishra, Konrad Aden, Johanna I. Blase, Nathan Baran, Dora Bordoni, Florian Tran, Claudio Conrad, Diana Avalos, Charlot Jaeckel, Michael Scherer, Signe B. Sørensen, Silja H. Overgaard, Berenice Schulte, Susanna Nikolaus, Guillaume Rey, Gilles Gasparoni, Paul A. Lyons, Joachim L. Schultze, Jörn Walter, Vibeke Andersen, SYSCID Consortium, Emmanouil T. Dermitzakis, Stefan Schreiber, Philip Rosenstiel
Publikováno v:
Genome Medicine, Vol 14, Iss 1, Pp 1-20 (2022)
Abstract Background and aims Treatment with tumor necrosis factor α (TNFα) antagonists in IBD patients suffers from primary non-response rates of up to 40%. Biomarkers for early prediction of therapy success are missing. We investigated the dynamic
Externí odkaz:
https://doaj.org/article/533221e6756c4c1d84dece9aba5649b6
Autor:
Vibeke Andersen, Tue B. Bennike, Corinna Bang, John D. Rioux, Isabelle Hébert-Milette, Toshiro Sato, Axel K. Hansen, Ole H. Nielsen
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 13, p 11217 (2023)
Inflammatory bowel diseases (IBD) are without cure and troublesome to manage because of the considerable diversity between patients and the lack of reliable biomarkers. Several studies have demonstrated that diet, gut microbiota, genetics and other p
Externí odkaz:
https://doaj.org/article/ee32ec1082d943fdb086edee4bb4c142
Autor:
Silja H. Overgaard, Signe B. Sørensen, Heidi L. Munk, Anders B. Nexøe, Henning Glerup, Rikke H. Henriksen, Tanja Guldmann, Natalia Pedersen, Sanaz Saboori, Lone Hvid, Jens F. Dahlerup, Christian L. Hvas, Mohamad Jawhara, Karina W. Andersen, Andreas K. Pedersen, Ole H. Nielsen, Fredrik Bergenheim, Jacob B. Brodersen, Berit L. Heitmann, Thorhallur I. Halldorsson, Uffe Holmskov, Anette Bygum, Robin Christensen, Jens Kjeldsen, Torkell Ellingsen, Vibeke Andersen
Publikováno v:
Frontiers in Nutrition, Vol 9 (2022)
BackgroundBiologic disease-modifying drugs have revolutionised the treatment of a number of chronic inflammatory diseases (CID). However, up to 60% of the patients do not have a sufficient response to treatment and there is a need for optimization of
Externí odkaz:
https://doaj.org/article/c7c7b849dd4040be86256b2d83b140d7